超声引导下经皮射频消融与激光消融治疗微小肝癌患者疗效初步比较研究

doi:10.3969/j.issn.1672-5069.2017.03.016

实用肝脏病杂志 ›› 2017, Vol. 20 ›› Issue (3): 320-323.doi: 10.3969/j.issn.1672-5069.2017.03.016

超声引导下经皮射频消融与激光消融治疗微小肝癌患者疗效初步比较研究

余红星, 陈颖, 刘自鹏, 张丽

723000 陕西省汉中市中心医院超声诊断科

收稿日期:2016-11-07 出版日期:2017-06-10 发布日期:2018-03-10
作者简介:余红星：男,41岁,大学本科,主治医师。主要从事超声影像学诊断及治疗学研究。E-mail:yuhongxing1975@163.com

Comparison of ultrasound-guided percutaneous laser ablation and radiofrequency ablation for the treatment of patients with small hepatocellular carcinoma

Yu Hongxing Chen Ying Liu Zipeng, et al.

Department of Ultrasound,Central Hospital,Hanzhong 723000,Shaanxi Province

Received:2016-11-07 Online:2017-06-10 Published:2018-03-10

摘要/Abstract

摘要： 目的比较超声引导下经皮激光消融（LA）与经皮射频消融（RFA）治疗微小肝癌患者的临床疗效。方法 54例微小（<2 cm）肝癌患者被分为LA组和RFA组,每组27例。比较两组疗效、肿瘤局部控制（LC）和无进展生存时间（PFS）。结果 LA组近期有效率（RR）为81.5%,与RFA组的77.8%比,差异无统计学意义（P>0.05）;RFA组一年LC为77.8%,显著高于LA组的51.9%,差异有统计学意义（P<0.05）; RFA组PFS为（12.5±6.6）个月,显著长于LA组的（8.7±5.1）个月,差异有统计学意义（P<0.05）;两组术后局部疼痛、腹腔出血、胆道出血和腹腔感染等并发症发生率无显著性相差（P>0.05）。结论与LA治疗比,RFA可提高治疗微小HCC患者的肿瘤局部控制率,并延长患者的肿瘤无进展生存时间,具有一定的临床应用价值。

关键词: 肝细胞癌, 激光消融, 射频消融, 无进展生存时间

Abstract: Objective To compare the efficacies of ultrasound-guided percutaneous laser ablation （LA） and radiofrequency ablation （RFA） for the treatment of patients with small hepatocellular carcinoma （HCC）. Methods We retrospectively analyzed the data of 54 patients with small HCC admitted to our department between 2010 and 2014. The patients with HCC were randomly divided into LA （n=27） and RFA group （n=27）. The response rates （RR）,local control （LC） rates and progression free survival （PFS） between the two groups were compared. Results The RR in LA group was 81.5%,not statistically significantly different compared with 77.8% （P>0.05） in the RFA group;The LC at the end of one year in RFA group was 77.8%,significantly higher than 51.9% in LA group （P<0.05）;The PFS in RFA group was （12.5±6.6） months,significantly longer than （8.7±5.1） months in LA group（P<0.05）;There was no significant difference as respect to the incidence of postoperative complications （P>0.05）. Conclusions RFA can improve LC,and prolong PFS in patients with small HCC,which warrants further clinical application.

Key words: Hepatoma, Laser ablation, Radiofrequency ablation, Progression free survival

余红星, 陈颖, 刘自鹏, 张丽. 超声引导下经皮射频消融与激光消融治疗微小肝癌患者疗效初步比较研究[J]. 实用肝脏病杂志, 2017, 20(3): 320-323.

Yu Hongxing Chen Ying Liu Zipeng, et al.. Comparison of ultrasound-guided percutaneous laser ablation and radiofrequency ablation for the treatment of patients with small hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(3): 320-323.

参考文献

[1] Torre LA,Bray F,Siegel RL,et al.Global cancerstatistics,2012. CA Cancer J Clin,2015,65(2):87-108.
[2] Benson AB,Abrams TA,Ben-Josef E,et al.NCCN clinical practice guidelines in oncology:hepatobiliary cancers. J Natl Compr Canc Netw,2009,7(4):350-391.
[3] 荚卫东. 精准肝脏外科时代肝癌多学科治疗. 实用肝脏病杂志,2015,18(2):120-123.
[4] Kinoshita A,Onoda H,Fushiya N,et al.Staging systems for hepatocellular carcinoma:Current status and future perspectives. World J Hepatol,2015,7(3):406-424.
[5] Lim C,Vibert E,Azoulay D,et al.Indocyanine green fluorescence imaging in the surgical management of liver cancers: current facts and future implications. J Visc Surg,2014,151(2):117-124.
[6] Rahbari NN,Mehrabi A,Mollberg NM,et al.Hepatocellular carcinoma:current management and perspectives for the future. Ann Surg,2011,253:453-469.
[7] 吴秀栓,李建生,许戈良,等. 超声造影在肝细胞癌诊断及治疗中的应用进展. 实用肝脏病杂志,2011,14(2):158-160.
[8] Selvaraj RJ,Sarin K,Singh VR,et al.Radiofrequency ablation of posteroseptal accessory pathways associated with coronary sinus diverticula. J Interv Card Electrophysiol,2016,47(2):253-259.
[9] Di Costanzo GG,D'Adamo G,Tortora R,et al. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol,2013,54(8):876-881.
[10] 任炜, 杨薇. 射频消融治疗复发性肝癌疗效及预后因素分析. 介入放射学杂志,2015,24(10):923-927.
[11] 杨薇. 影像引导射频消融治疗较大肝癌的现状及前景. 世界华人消化杂志,2015,23(30):4771-4777.
[12] Eichler K,Zangos S,Gruber-Rouh T,et al.MR-guided laser-induced thermotherapy(LITT) in patients with liver metastases of unveal melanoma. J Eur Acad Dermatol Venereol,2014,28(12):1756-1760.
[13] 喻昊,俞花,李晓欢,等. 小肝细胞癌术后早期复发的危险因素分析. 实用肝脏病杂志,2016,19(3):358-360.
[14] Kudo M.Recent trends in the management of hepatocellular carcinoma with special emphasis on treatment with regorafenib and immune checkpoint inhibitors. Dig Dis,2016,34(6):714-730.
[15] 杨家进,吴建兵. 原发性肝癌综合介入治疗进展. 实用肝脏病杂志,2015,18(2):118-119.
[16] 李金瑞,钟鑫平. 射频消融联合DC-CIK治疗中晚期肝细胞癌的疗效评价. 检验医学与临床,2015,12(19):2830-2833.
[17] 黄真辉,聂生东. 经皮激光消融技术应用研究进展. 生物医学工程学进展,2014,35(4):228-232.
[18] Lehmann KS,Frericks BB,Holmer C,et al.In vivo validation of a therapy planning system for laser-induced thermotherapy (LITT) of liver malignancies. Int J Colorectal Dis,2011,26(6):799-808.
[19] 朱东升,吴志华,彭国林,等. 超声引导下经皮穿刺治疗门静脉癌栓的疗效探讨. 临床超声医学杂志,2015,17(7):488-490.

超声引导下经皮射频消融与激光消融治疗微小肝癌患者疗效初步比较研究

Comparison of ultrasound-guided percutaneous laser ablation and radiofrequency ablation for the treatment of patients with small hepatocellular carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[2]	朱俊, 丁莹, 王世清, 张野, 刘野, 刘泽刚. 围手术期应用乌司他丁治疗对肝细胞癌患者肝切除术后外周血Th22细胞百分比和血浆白细胞介素-22的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 720-723.
[3]	王刚, 赵洪波, 朱亚玲, 蒋保三, 张越美, 刁勇. 基于数据库分析肝细胞癌细胞XPO5基因水平变化及其临床意义*[J]. 实用肝脏病杂志, 2019, 22(5): 724-727.
[4]	戴青云, 王润东, 荚卫东. 术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨^*[J]. 实用肝脏病杂志, 2019, 22(4): 561-564.
[5]	杨富存, 尚怀学, 盖永浩. 钆塞酸二钠增强磁共振扫描诊断肝脏局灶性病变研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 577-580.
[6]	彭新健, 肖玉辉, 许斯鼎, 石荣跃, 王耀政, 王瑜琳. 放射性肝损伤患者肝脏磁共振扩散加权成像表现特征分析[J]. 实用肝脏病杂志, 2019, 22(3): 373-376.
[7]	乔志忠. 超声造影定量分析鉴别肝脏局灶性结节性增生与原发性肝癌初步探讨[J]. 实用肝脏病杂志, 2019, 22(3): 421-424.
[8]	朱光曦（综述）, 文良志, 陈东风（审校）. 非酒精性脂肪性肝病相关肝细胞癌发病机制研究进展[J]. 实用肝脏病杂志, 2019, 22(3): 453-456.
[9]	王虎明,樊东升,徐杰,刘险峰,周宁,丽敏,包娜娜. 肝细胞癌患者癌组织miRNA-30c水平变化及其临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(2): 248-251.
[10]	幸奠奎,程婧. ¹⁸F-FDG PET/CT检查指标预测肝细胞癌微血管侵犯临床价值研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 252-254.
[11]	王秀清,马艳君,詹晋莉. 肝动脉化疗栓塞术联合超声引导下微波消融术治疗特殊部位原发性肝癌患者疗效及安全性分析 ^*[J]. 实用肝脏病杂志, 2019, 22(2): 260-263.
[12]	张小舟,帅领,王庆大,杨楠. 接受TACE治疗的肝细胞癌患者血清miR-335水平变化及其对预后判断的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(2): 268-271.
[13]	王朝霞,关珂,付三仙,王慧杰. 肠内肠外联合营养支持治疗肝细胞癌患者围术期临床研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 272-275.
[14]	赵西太综述,聂青和审校. 循环microRNA早期诊断肝细胞癌研究现状及方法学探讨[J]. 实用肝脏病杂志, 2019, 22(2): 297-300.
[15]	范建高. 2018年《实用肝脏病杂志》精彩回顾[J]. 实用肝脏病杂志, 2019, 22(1): 1-3.